Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.59071 | 24 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.58125 | 25 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.57971 | 25 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.54327 | 26 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.52255 | 24 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.64939 | 25 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.58906 | 24 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.55924 | 25 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.5572 | 25 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.57401 | 25 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.56771 | 25 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.53921 | 24 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.56989 | 25 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.57037 | 25 |